-
EP3914708
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3914708
| EP3914708 - NUCLEIC ACID NANOSTRUCTURE PLATFORM FOR ANTIGEN PRESENTATION AND VACCINE FORMULATIONS FORMED THEREFROM [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 29.10.2021 Database last updated on 28.05.2024 | |
| Former | The international publication has been made Status updated on 03.08.2020 | ||
| Former | unknown Status updated on 18.03.2020 | Most recent event Tooltip | 29.01.2024 | New entry: Renewal fee paid | Applicant(s) | For all designated states MASSACHUSETTS INSTITUTE OF TECHNOLOGY 77 Massachusetts Avenue Cambridge, MA 02139 / US | [2021/48] | Inventor(s) | 01 /
BATHE, Mark 17 Perry Street Unit 1 Cambridge, Massachusetts 02139 / US | 02 /
VENEZIANO, Remi 11800 Laurestine Way 309 Manassas, Virginia 20109 / US | 03 /
WAMHOFF, Eike-Christian 174 Harvard Street Brookline, Massachusetts 02446 / US | 04 /
MOYER, Tyson 1 Devonshire Place Apt. 1114 Boston, Massachusetts 02109 / US | 05 /
READ, Benjamin Joseph 229 Vassar Street Apt. 621 Cambridge, Massachusetts 02139 / US | 06 /
IVRINE, Darrell 17 Gray Street Arlington, Massachusetts 02476 / US | [N/P] |
| Former [2021/48] | 01 /
BATHE, Mark Cambridge, Massachusetts 02139 / US | ||
| 02 /
VENEZIANO, Remi Manassas, Virginia 20109 / US | |||
| 03 /
WAMHOFF, Eike-Christian Brookline, Massachusetts 02446 / US | |||
| 04 /
MOYER, Tyson Boston, Massachusetts 02109 / US | |||
| 05 /
READ, Benjamin Joseph Cambridge, Massachusetts 02139 / US | |||
| 06 /
IVRINE, Darrell Arlington, Massachusetts 02476 / US | Representative(s) | Potter Clarkson Chapel Quarter Mount Street Nottingham NG1 6HQ / GB | [N/P] |
| Former [2021/48] | Potter Clarkson The Belgrave Centre Talbot Street Nottingham NG1 5GG / GB | Application number, filing date | 20709799.9 | 24.01.2020 | [2021/48] | WO2020US14957 | Priority number, date | US201962796472P | 24.01.2019 Original published format: US 201962796472 P | [2021/48] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2020154595 | Date: | 30.07.2020 | Language: | EN | [2020/31] | Type: | A1 Application with search report | No.: | EP3914708 | Date: | 01.12.2021 | Language: | EN | The application published by WIPO in one of the EPO official languages on 30.07.2020 takes the place of the publication of the European patent application. | [2021/48] | Search report(s) | International search report - published on: | EP | 30.07.2020 | Classification | IPC: | C12N15/11, G16B15/10, A61K39/12, A61P31/18, A61K39/21, C07K14/16 | [2021/48] | CPC: |
A61K39/12 (EP);
A61K39/385 (US);
A61K39/21 (EP,US);
A61K9/0019 (EP);
A61K9/513 (EP);
A61P31/18 (EP);
C07K14/162 (EP);
C12N15/11 (EP);
A61K2039/55588 (US);
A61K2039/6025 (EP,US);
A61K2039/6093 (US);
A61K2039/64 (EP,US);
B82Y5/00 (EP);
C12N2310/51 (EP);
G16B15/10 (EP);
G16B40/10 (EP)
(-)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2021/48] | Title | German: | NUKLEINSÄURENANOSTRUKTURPLATTFORM ZUR ANTIGENPRÄSENTATION UND DARAUS HERGESTELLTE IMPFSTOFFFORMULIERUNGEN | [2021/50] | English: | NUCLEIC ACID NANOSTRUCTURE PLATFORM FOR ANTIGEN PRESENTATION AND VACCINE FORMULATIONS FORMED THEREFROM | [2021/48] | French: | PLATEFORME DE NANOSTRUCTURE D'ACIDE NUCLÉIQUE POUR PRÉSENTATION D'ANTIGÈNE ET FORMULATIONS DE VACCIN FORMÉES GRÂCE À SON UTILISATION | [2021/48] |
| Former [2021/48] | NUCLEIC ACID NANOSTRUCTURE PLATFORM FOR ANTIGEN PRESENTATION AND VACCINE FORMULATIONS FORMED THEREFROM | Entry into regional phase | 23.08.2021 | National basic fee paid | 23.08.2021 | Designation fee(s) paid | 23.08.2021 | Examination fee paid | Examination procedure | 23.08.2021 | Examination requested [2021/48] | 23.08.2021 | Date on which the examining division has become responsible | 12.04.2022 | Amendment by applicant (claims and/or description) | Fees paid | Renewal fee | 23.08.2021 | Renewal fee patent year 03 | 27.01.2023 | Renewal fee patent year 04 | 29.01.2024 | Renewal fee patent year 05 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [XY]WO2017189870 (MASSACHUSETTS INST TECHNOLOGY [US]) [X] 1-14,20-45,63-72 *** pages 79, 95, 110 *** [Y] 15-19,46-50,61,62,73,74; | [Y] - JOSEPH JARDINE ET AL, "Rational HIV Immunogen Design to Target Specific Germline B Cell Receptors", SCIENCE, (20130510), vol. 340, doi:10.1126/science.1234150, pages 711 - 716, XP055548938 [Y] 1-50,61-74 *** Figure 3, page 713 center col., page 714 right col. *** DOI: http://dx.doi.org/10.1126/science.1234150 | [Y] - J. G. JARDINE ET AL, "Supplementary Materials for Priming a broadly neutralizing antibody response to HIV-1 using a germline-targeting immunogen", SCIENCE, US, (20150618), vol. 349, no. 6244, doi:10.1126/science.aac5894, ISSN 0036-8075, pages 156 - 161, XP055548843 [Y] 1-50,61-74 *** page 157 center col., page 161 left col. *** DOI: http://dx.doi.org/10.1126/science.aac5894 | [A] - R. VENEZIANO ET AL, "Designer nanoscale DNA assemblies programmed from the top down", SCIENCE, US, (20160526), vol. 352, no. 6293, doi:10.1126/science.aaf4388, ISSN 0036-8075, pages 1534 - 1534, XP055392399 [A] 1-50,61-74 DOI: http://dx.doi.org/10.1126/science.aaf4388 | [XP] - REMI VENEZIANO ET AL, "Probing the Role of HIV Antigen Nanoscale Organization on B-Cell Activation with DNA Origami", BIOPHYSICAL JOURNAL, AMSTERDAM, NL, (20190201), vol. 116, no. 3, doi:10.1016/j.bpj.2018.11.3109, ISSN 0006-3495, pages 578a - 578a, XP055691232 [XP] 1-50,61-74 * abstract * DOI: http://dx.doi.org/10.1016/j.bpj.2018.11.3109 | by applicant | WO9633739 | WO9836772 | US2003215914 | US2005147962 | US2005220814 | US2011206758 | US2014356384 | US9149520 | CN106119269 | WO2017089567 | WO2017089570 | - BURTON et al., Science, (20120000), vol. 338, no. 6091, pages 1177 - 1183 | - BURNETT et al., Science, (20180000), vol. 359, no. 6373, pages 343 - 347 | - CORTI, D.LANZAVECCHIA, A., Annu. Rev. Immunol., (20130000), vol. 31, pages 705 - 742 | - SIMEK et al., J. Virol., (20090000), vol. 83, no. 14, pages 7337 - 7348 | - LIAO et al., Nature, (20130000), vol. 496, no. 7446, pages 469 - 476 | - LI et al., Nat. Med., (20070000), vol. 13, no. 9, pages 1032 - 1034 | - WU et al., Science, (20100000), vol. 329, no. 5993, pages 856 - 861 | - SCHUMACHERSCHREIDBER, Science, (20150000), vol. 348, no. 6230, pages 156 - 161 | - JARDINE et al., Science, (20130000), vol. 340, no. 6133, pages 711 - 6 | - ABBOTT et al., Immunity, (20180000), vol. 48, no. 1, pages 133 - 146.e6 | - KOUSKOFF et al., Journal of Experimental Medicine, (19980000), vol. 188, no. 8, pages 1453 - 64 | - VENEZIANO, R et al., Science, (20160000), vol. 352, no. 6293, pages 1534 - 63 | - PRAETORIUS et al., Nature, (20170000), vol. 552, pages 84 - 87 | - CHASTEEN et al., Nature, (20060000), vol. 440, no. 7095, pages e145 - 302 | - KLEIN, JS.BJORKMAN, PJ., PLOS Pathog., (20100000), vol. 6, no. 5, page e1000908 | - ITO et al., "Cancer Neoantigens: A Promising Source of Immunogens for Cancer Immunotherapy", J Clin Cell Immunol, (20150000), vol. 6, page 322 | - GETTS D RGETTS M TMCCARTHY D PCHASTAIN E M LMILLER S D, mAbs, (20100000), vol. 2, no. 6, pages 682 - 694 | - WINFREE, E et al., Nature, (19980000), vol. 394, no. 6693, pages 539 - 544 | - ROTHEMUND PWK et al., PLoS Biol., (20040000), vol. 2, pages 2041 - 2053 | - YAN, H et al., Science, (20030000), vol. 301, pages 1882 - 1884 | - TOKATLIAN et al., "Enhancing Humoral Responses Against HIV Envelope Trimers via Nanoparticle Delivery with Stabilized Synthetic Liposomes", Scientific Reports, (20180000), vol. 8, no. 6548 | - OKHOLM et al., Methods, (20140000), vol. 67, no. 2, pages 193 - 7 | - DAHLMAN et al., Proc Natl Acad Sci USA, (20170000), vol. 114, no. 8, pages 2060 - 65 | - BOBBIN et al., Genome Med., (20150000), vol. 7, no. 1, page 50 | - WAHLESTEDT C et al., Proc. Natl Acad. Sci. USA, (20000000), pages 975633 - 5638 | - BRAASCH, DA et al., Chem. Biol., (20010000), pages 81 - 7 | - KURRECK J et al., Nucleic Acids Res., (20020000), pages 301911 - 1918 | - NIELSEN PE et al., Science, (19910000), vol. 254, pages 1497 - 1500 | - BUJOLD et al., Chem. Sci., (20140000), vol. 5, pages 2449 - 2455 | - GOVAN et al., Bioconjugate Chem., (20110000), vol. 22, no. 10, pages 2136 - 2142 | - CONWAY et al., Chem. Commun., (20130000), vol. 49, pages 1172 - 1174 | - PONNUSWAMY et al., Nat. Commun., (20170000), vol. 8, page 15654 | - KIVIAHO et al., Nanoscale, (20180000), vol. 10, pages 11674 - 11680 | - TUITE et al., Eur J Biochem, (19970000), vol. 243, no. 1, pages 482 - 492 | - KAWAMOTO et al., Bioorg Med Chem, (20180000), vol. 26, no. 8, pages 1393 - 1411 | - DICKINSON et al., Proc Natl Acad Sci USA, (19980000), vol. 95, no. 22, pages 12890 - 5 | - OYOSHI et al., JAm Chem Soc, (20030000), vol. 125, no. 16, pages 4752 - 4 | - MORITA et al., J Clin Invest, (20170000), vol. 127, no. 7, pages 2815 - 2828 | - SHIH et al., Nature, (20040000), vol. 427, no. 6975, pages 618 - 21 | - DIETZ, H. et al., Science, (20090000), vol. 325, pages 725 - 730 | - DOUGLAS, S.M. et al., Nature, (20090000), vol. 459, pages 414 - 418 | - BROWN, S et al., Nanoscale, (20150000), vol. 7, pages 16621 - 16624 | - MARCHI, A.N. et al., Nano Lett, (20140000), vol. 14, pages 5740 - 5747 | - BENSON, E et al., Nature, (20150000), vol. 523, pages 441 - 444 | - DOUGLAS, S.M. et al., Nucleic Acids Res, (20090000), vol. 37, pages 5001 - 5006 | - ZHANG et al., Nat Nanotechnol., (20150000), vol. 10, no. 9, pages 779 - 84 | - KE, Y et al., Nat Chem, (20140000), vol. 6, pages 994 - 1002 | - ELBAZ, J et al., Nat Commun, (20160000), vol. 7, page 11179 | - GEARY, C et al., Science, (20140000), vol. 345, pages 799 - 804 | - NICKELS, P.C. et al., Small, (20140000), vol. 10, pages 1765 - 1769 | - HAN et al., Science, (20170000), vol. 358, no. 6369 | - KICK, B et al., Nana Lett, (20150000), vol. 15, pages 4672 - 4676 | - LIU et al., Angew. Chem. Int. Ed., (20110000), vol. 50, pages 264 - 267 | - ZHAO et al., Nano Lett., (20110000), vol. 11, pages 2997 - 3002 | - WOO et al., Nat. Chem., (20110000), vol. 3, pages 620 - 627 | - TORRING et al., Chem. Soc. Rev., (20110000), vol. 40, pages 5636 - 5646 | - SACCA et al., Angew Chem Int Ed Engl., (20100000), vol. 49, no. 49, pages 9378 - 83 | - MORELLI et al., J Med Microbiol., (20120700), vol. 61, pages 935 - 43 | - WILSON et al., Journal of immunology, (20140000), vol. 192, no. 7, pages 3259 - 68 | - FOUSTERI et al., Diabetologia, (20100000), vol. 53, pages 1958 - 1970 | - BABER, Nat Rev Immunol., (20150000), vol. 15, no. 12, pages 760 - 770 | - VENEZIANO et al., Sci. Rep., (20180000), vol. 8, no. 1, page 6548 | - SIL et al., ACS Chem. Biol., (20070000), vol. 2, no. 10, pages 674 - 84 | - COCHRAN et al., J. Biol. Chem., (20010000), vol. 276, no. 30, pages 28068 - 28074 | - YANG et al., Nature, (20100000), vol. 467, no. 7314, pages 465 - 469 | - SHEPHERD, Sci Rep, (20190000), vol. 9, no. 1, page 61212 |